In a translational approach, we compared the DPP4 activity in serum from 34 infants with confirmed BA, obtained at the time of KPE, with the DPP4 activity in serum from 14 immunologically healthy infants who underwent routine surgery (e.g. hernia repair). The gene discussed is DPP4; the disease is breast angiosarcoma.